Indian Journal of Allergy, Asthma and Immunology

REVIEW ARTICLE
Year
: 2018  |  Volume : 32  |  Issue : 2  |  Page : 43--46

Future modalities in allergen immunotherapy: A brief overview


SN Gaur 
 Department of Respiratory Medicine, School of Medical Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, India

Correspondence Address:
Dr. S N Gaur
Department of Respiratory Medicine, School of Medical Sciences and Research, Sharda University, Knowledge Park-III, Greater Noida - 201 306, Uttar Pradesh
India

Allergen immunotherapy (AIT) is the only disease-modifying modality for the treatment of allergic diseases. The well-known and approved formulations are subcutaneous immunotherapy (SCIT), sublingual immunotherapy (SLIT) and allergoids. The drawbacks of the conventional AIT such as the risk of anaphylaxis led to the development of allergoids, Future approaches in AIT may permit (1) shorter treatment regimens, (2) improved safety, (3) improved compliance and (4) newer indications for AIT, which are discussed in the article.


How to cite this article:
Gaur S N. Future modalities in allergen immunotherapy: A brief overview.Indian J Allergy Asthma Immunol 2018;32:43-46


How to cite this URL:
Gaur S N. Future modalities in allergen immunotherapy: A brief overview. Indian J Allergy Asthma Immunol [serial online] 2018 [cited 2019 Jan 20 ];32:43-46
Available from: http://www.ijaai.in/article.asp?issn=0972-6691;year=2018;volume=32;issue=2;spage=43;epage=46;aulast=Gaur;type=0